About
Biologics
Areas of Focus
Categories
Biologics & BiopharmaceuticalJapan
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
282
By Phase
PHASE3: 2PHASE1/PHASE2: 3
By Status
UNKNOWN: 3RECRUITING: 1COMPLETED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT05627648Lead Sponsor
Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar
PHASE3Recruiting
62 participants
Started: Dec 1, 2022 · Completed: Aug 31, 2026
NCT04475224Lead Sponsor
Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury
PHASE3Unknown
25 participants
Started: Jul 13, 2020 · Completed: Jun 30, 2023
NCT02193334Lead Sponsor
Phase I/II Study of KP-100IT in Acute Spinal Cord Injury
PHASE1/PHASE2Completed
45 participants
Started: Jun 30, 2014 · Completed: Jul 31, 2018
NCT00797706Lead Sponsor
Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
PHASE1/PHASE2Unknown
75 participants
Started: Nov 30, 2008 · Completed: Mar 31, 2010
NCT00797706Collaborator
Phase I/II Dose Ranging CHRONSEAL® Study in Venous Leg Ulcers
PHASE1/PHASE2Unknown
75 participants
Started: Nov 30, 2008 · Completed: Mar 31, 2010
Locations (1)
Headquarters
Ibaraki, Japan
Map
Loading map...